Diabetic patients with COVID-19 need more attention and better glycemic control

Table 1 Clinical characteristics in terms of diabetes in coronavirus disease 2019 patients (n = 61)

		Total	Diabetes		P value
			No	Yes
Sample, n (%)		61 (100)	46 (75.4)	15 (24.6)
Sex, n (%)
	Male	33 (54.1)	24 (52.2)	9 (60.0)	0.767
	Female	28 (45.9)	22 (47.8)	6 (40.0)
Age [mean (SD)]		63.62 (10.78)	62.96 (10.71)	65.60 (11.11)	0.415
Hypertension, n (%)
	No	38 (62.3)	32 (69.6)	6 (40.0)	0.065
	Yes	23 (37.7)	14 (30.4)	9 (60.0)
Heart diseases, n (%)
	No	54 (88.5)	42 (91.3)	12 (80.0)	0.348
	Yes	7 (11.5)	4 (8.7)	3 (20.0)
Lung involvement based on CT findings, n (%)
	Large-moderate	22 (36.1)	16 (34.8)	6 (40.0)	0.763
	Mild-none	39 (63.9)	30 (65.2)	9 (60.0)
Lung involvement progression, n (%)
	Better	42 (68.9)	29 (63.0)	13 (86.7)	0.509
	Still	16 (26.2)	14 (30.5)	2 (13.3)
	Worse	3 (4.9)	3 (6.5)	0 (0.0)
Laboratory findings, n (%)1
	Normal	18 (29.5)	13 (28.3)	5 (33.3)	0.751
	With abnormal value	43 (70.5)	33 (71.7)	10 (66.7)
Treatments, n (%)
	Non-invasive	33 (54.1)	29 (63.0)	4 (53.3)	0.02
	Invasive	28 (45.9)	17 (27.0)	11 (46.7)
Severity, n (%)
	Mild	44 (72.1)	38 (82.6)	6 (40.0)	0.003
	Severe	17 (27.9)	8 (17.4)	9 (60.0)

¹Detailed laboratory findings are listed in Table 2. CT: Computed tomography.